Ravi Sahu | Pharmacology | Best Researcher Award

Best Researcher Award

Ravi Sahu – Wright State University Boonshoft School of Medicine

Ravi Sahu
Affiliation Wright State University Boonshoft School of Medicine
Country United States
Scopus ID 36833607800
Documents 1076
Citations 1372
h-index 23
Subject Area Pharmacology
Event World Top Scientist Awards
ORCID 0000-0003-3857-9073

Ravi Sahu is a pharmacology researcher associated with Wright State University Boonshoft School of Medicine in the United States. His research profile demonstrates a consistent contribution to biomedical sciences, particularly in cancer pharmacology and molecular therapeutics. The recognition under the Best Researcher Award category reflects scholarly output, citation impact, and involvement in global research collaborations. His work has contributed to advancing understanding in cancer biology, immunotherapy, and drug repurposing strategies [1].

Abstract

This article presents an academic overview of Ravi Sahu, emphasizing his scholarly contributions in pharmacology and cancer research. His work spans experimental therapeutics, immunological pathways, and drug repurposing strategies. The evaluation is based on bibliometric indicators including citation count, h-index, and research output. The profile aligns with international standards used in academic recognition systems [2].

Keywords

Pharmacology, Cancer Research, Immunotherapy, Drug Repurposing, Molecular Biology, Oncology, Research Metrics.

Introduction

The field of pharmacology has evolved significantly with the integration of molecular biology and translational medicine. Researchers such as Ravi Sahu have contributed to bridging laboratory findings with clinical applications. His research focuses on understanding cellular signaling pathways and developing therapeutic interventions. These efforts contribute to improved treatment strategies in oncology [3].

Research Profile

The research profile of Ravi Sahu indicates substantial scholarly output with over a thousand indexed documents and a growing citation base. His work is indexed in major academic databases including Scopus and ORCID. The profile reflects interdisciplinary collaboration and sustained research productivity. These indicators are commonly used to assess academic performance globally [1].

Research Contributions

Ravi Sahu has contributed to multiple areas including cancer therapeutics, platelet-activating factor signaling, and immune checkpoint research. His publications explore mechanisms of tumor progression and therapeutic resistance. The research also includes investigations into repurposed drugs such as metformin and itraconazole. These contributions enhance understanding of treatment optimization strategies [4].

Publications

The publication record includes peer-reviewed journal articles across high-impact biomedical journals. Notable works include studies on lung cancer therapies, melanoma treatment, and molecular signaling pathways. The research demonstrates both experimental and review-based scholarship. These publications contribute to advancing scientific knowledge and clinical practices [5].

Research Impact

The research impact of Ravi Sahu is reflected through citation metrics and academic collaborations. His work has been cited in multiple interdisciplinary studies, indicating relevance across scientific domains. The h-index value highlights consistent scholarly influence. Such metrics are critical in evaluating research visibility and academic significance [2].

Award Suitability

The Best Researcher Award recognizes individuals demonstrating excellence in scientific research and innovation. Ravi Sahu’s academic record meets key criteria including publication output, citation impact, and subject expertise. His involvement in international research initiatives further strengthens his eligibility. These factors collectively support recognition at global scientific platforms [3].

Conclusion

Ravi Sahu’s contributions to pharmacology and cancer research demonstrate sustained academic excellence. His work integrates molecular insights with therapeutic applications, contributing to advancements in biomedical science. The recognition under the Best Researcher Award highlights the significance of his scholarly achievements. Continued research efforts are expected to further enhance his impact in the scientific community [4].

References

  1. Elsevier. (n.d.). Scopus author details: Ravi Sahu, Author ID 36833607800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36833607800
  2. Sahu, R. P., Zonfa, C. E., & Thyagarajan, A. (2026). Repurposing itraconazole in combination with chemotherapy and immune checkpoint inhibitor for cancer. Medical Sciences, 14(1), 55.
    https://doi.org/10.3390/medsci14010055

  3. Thyagarajan, A., Gajjar, V., & Sahu, R. P. (2025). Are metformin-based combination approaches beneficial for non-small cell lung cancer: Evidence from experimental and clinical studies. Military Medical Research, 12, 61.
    https://doi.org/10.1186/s40779-025-00649-5

  4. Sahu, R. P., et al. (2025). Platelet-activating factor signaling in cancer. Journal of Applied Toxicology. Advance online publication. https://doi.org/10.1002/jat.4770

  5. Sahu, R. P., et al. (2023). Melatonin in melanoma treatment. Medical Sciences, 11(1), 9.

    https://doi.org/10.3390/medsci11010009

     

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Senior Consultant at Department of Oral and Maxillofacial Surgery / Plastic surgery, University Medicine Lübeck, Germany

Dr. med. Christian Seebauer, MD, DDS, is a distinguished clinician-scientist with dual qualifications in medicine and dentistry and board certifications in Oral and Maxillofacial Surgery and Oral Surgery. Currently a Senior Consultant at University Medical Center Lübeck, he has held several leadership roles in academic surgery. His research focuses on innovative therapies such as cold atmospheric plasma for cancer, wound healing, and oral diseases. He has authored impactful publications in high-ranking journals, with a strong emphasis on translational and interdisciplinary research. Awarded a summa cum laude for his medical doctorate, he is pursuing a second doctorate in dental medicine and a habilitation. Dr. Seebauer is actively involved in clinical trials, academic teaching, and scientific advising. His work reflects a commitment to advancing patient care through science, collaboration, and clinical excellence, making him a highly suitable candidate for prestigious research recognition such as the Best Researcher Award.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Christian Seebauer’s educational background reflects his exceptional commitment to interdisciplinary medical science. He earned his medical degree from Friedrich-Schiller-University Jena in 2006, graduating with high distinction and obtaining his medical license with a “very good” grade. Driven by an interest in craniofacial care, he pursued a second degree in dentistry at Ernst-Moritz-Arndt-University Greifswald, earning his dental license in 2015, again with top marks. He completed specialist training in Oral and Maxillofacial Surgery (2020) and Oral Surgery (2021), and is on track to receive an additional qualification in Plastic and Aesthetic Surgery by 2025. Academically, he achieved his Doctor of Medicine (summa cum laude) from Charité – Berlin in 2012, is completing a second doctorate in dental medicine, and is preparing his habilitation at University Medical Center Lübeck. His dual training uniquely equips him for complex surgical, academic, and translational roles in modern healthcare.

Professional Experience

Dr. Seebauer has accumulated extensive clinical and academic experience in leading German medical institutions. He began his residency in musculoskeletal surgery at Charité – Berlin (2007–2010), then transitioned into Oral and Maxillofacial Surgery at University Medical Centers in Jena and Greifswald. At Greifswald, he steadily advanced from resident to Specialist, then Senior Consultant, and eventually Managing Senior Consultant by 2023. In August 2024, he was appointed Senior Consultant at the University Medical Center Lübeck. Throughout his career, he has taken on multiple responsibilities beyond patient care, including roles in transfusion medicine, radiation safety, and medical coding. Dr. Seebauer is experienced in running clinical trials, mentoring young surgeons, and integrating advanced surgical techniques such as microvascular tissue transfer and plasma-based therapies. His professional trajectory demonstrates continuous growth in clinical leadership, academic excellence, and institutional trust, confirming his status as a respected authority in surgical and translational medicine.

Research Interest

Dr. Seebauer’s research centers on innovative, translational approaches to oral, mucosal, and dermal disease management, with a particular emphasis on cold atmospheric plasma. His work spans a range of high-impact medical themes, including wound healing, cancer therapy, precancerous lesions, chronic inflammation, and alternative cancer treatments. He has contributed significantly to both preclinical and clinical investigations, exploring how plasma technologies can improve outcomes in head and neck cancer, oral lichen planus, and leukoplakia. His recent studies include cohort analyses on the effects of anticoagulants on wound healing and the global impact of HPV vaccination on malignancy risks. He is actively involved in the planning of prospective, multicenter clinical trials and collaborates internationally via networks like TriNetX. His multidisciplinary approach combines surgery, oncology, immunology, and biomedical engineering, showcasing his ability to merge clinical insight with experimental innovation. These interests place him at the forefront of translational medical research in Europe.

Award and Honor

Dr. Christian Seebauer has earned several distinctions throughout his academic and clinical career. He was awarded his Doctor of Medicine degree summa cum laude, one of the highest academic honors in Germany, by the prestigious Charité – University Medical Center Berlin. His scientific work has been published in internationally renowned, peer-reviewed journals such as Radiology, Oral Diseases, and Pharmacological Research, some with impact factors exceeding 10. He has held trusted leadership roles, including Managing Senior Consultant, and serves as a Scientific Advisor to neoplas MED. His selection for these positions reflects institutional recognition of his scientific and clinical integrity. Although not explicitly listed, his rising trajectory in academic medicine and involvement in high-level research projects suggest a strong reputation within professional circles. His affiliations with organizations such as the National Center for Plasma Medicine and Rotary Club also highlight his commitment to service and excellence beyond his clinical duties.

Conclusion

Dr. Christian Seebauer exemplifies the ideal candidate for recognition as a Best Researcher. With dual qualifications in medicine and dentistry, a track record of clinical leadership, and a deep commitment to translational research, he bridges the gap between scientific discovery and patient care. His pioneering work in cold atmospheric plasma and its applications in oncology and regenerative medicine is both innovative and impactful, reflecting future-forward thinking in clinical science. His publication record, leadership roles, and collaborative involvement in global research initiatives further establish his credibility and influence in the medical community. Dr. Seebauer’s academic path—marked by excellence, versatility, and continual advancement—underscores his dedication to improving healthcare through research, education, and clinical innovation. As he continues his habilitation and leads new clinical trials, his contributions are poised to shape future standards in surgery and therapeutic technology. He is highly deserving of prestigious accolades such as the Best Researcher Award.

Publications Top Notes

  • Title: Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer

    • Authors: HR Metelmann, C Seebauer, V Miller, A Fridman, G Bauer, DB Graves, …

    • Year: 2018

    • Citations: 353

  • Title: Head and neck cancer treatment and physical plasma

    • Authors: HR Metelmann, DS Nedrelow, C Seebauer, M Schuster, T von Woedtke, …

    • Year: 2015

    • Citations: 256

  • Title: Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment

    • Authors: ML Semmler, S Bekeschus, M Schäfer, T Bernhardt, T Fischer, K Witzke, …

    • Year: 2020

    • Citations: 216

  • Title: Comprehensive clinical plasma medicine: cold physical plasma for medical application

    • Authors: HR Metelmann, T Von Woedtke, KD Weltmann

    • Year: 2018

    • Citations: 162

  • Title: Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer

    • Authors: M Schuster, C Seebauer, R Rutkowski, A Hauschild, F Podmelle, …

    • Year: 2016

    • Citations: 152

  • Title: Cold atmospheric pressure plasma in wound healing and cancer treatment

    • Authors: L Boeckmann, M Schäfer, T Bernhardt, ML Semmler, O Jung, G Ojak, …

    • Year: 2020

    • Citations: 100

  • Title: Treating cancer with cold physical plasma: On the way to evidence‐based medicine

    • Authors: HR Metelmann, C Seebauer, R Rutkowski, M Schuster, S Bekeschus, …

    • Year: 2018

    • Citations: 65

  • Title: Hyperspectral imaging for in vivo monitoring of cold atmospheric plasma effects on microcirculation in treatment of head and neck cancer and wound healing

    • Authors: R Rutkowski, M Schuster, J Unger, C Seebauer, HR Metelmann, …

    • Year: 2017

    • Citations: 58

  • Title: Ankle laxity: stress investigation under MRI control

    • Authors: CJ Seebauer, HJ Bail, JC Rump, B Hamm, T Walter, UKM Teichgräber

    • Year: 2013

    • Citations: 55

  • Title: Side effects in cold plasma treatment of advanced oral cancer—Clinical data and biological interpretation

    • Authors: M Schuster, R Rutkowski, A Hauschild, RK Shojaei, T von Woedtke, …

    • Year: 2018

    • Citations: 48

  • Title: Physical plasma and leukocytes–immune or reactive?

    • Authors: S Bekeschus, C Seebauer, K Wende, A Schmidt

    • Year: 2018

    • Citations: 42

  • Title: Plasmamedizin

    • Authors: HR Metelmann, T von Woedtke, KD Weltmann

    • Year: 2016

    • Citations: 42

  • Title: Cold argon plasma as adjuvant tumour therapy on progressive head and neck cancer: A preclinical study

    • Authors: S Hasse, C Seebauer, K Wende, A Schmidt, HR Metelmann, …

    • Year: 2019

    • Citations: 41

  • Title: Third molars and periodontal damage of second molars in the general population

    • Authors: S Kindler, B Holtfreter, T Koppe, M Mksoud, C Lucas, C Seebauer, …

    • Year: 2018

    • Citations: 36

  • Title: Plasma-derived reactive species shape a differentiation profile in human monocytes

    • Authors: E Freund, J Moritz, M Stope, C Seebauer, A Schmidt, S Bekeschus

    • Year: 2019

    • Citations: 34